New treatment options approved

New medicine options approved after problems hit supply of depression treatments  The Therapeutic Goods Administration has approved new overseas options after problems were revealed regarding the availability of a couple of depression treatments - Nardil and Parnate. Two sponsors have been authorised to supply overseas-registered brands of phenelzine. These will replace Nardil, which was announced